相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance
Chune Ren et al.
CELL DEATH AND DIFFERENTIATION (2022)
Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma
Yujia Xu et al.
BLOOD (2021)
Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1
Dan Zhu et al.
CELL DEATH AND DIFFERENTIATION (2021)
OTUB1 Promotes Progression and Proliferation of Prostate Cancer via Deubiquitinating and Stabling Cyclin E1
Yihao Liao et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
OTUB1 facilitates bladder cancer progression by stabilizing ATF6 in response to endoplasmic reticulum stress
Hui-Hui Zhang et al.
CANCER SCIENCE (2021)
OTUB1 prevents lethal hepatocyte necroptosis through stabilization of c-IAP1 during murine liver inflammation
Josephin Koschel et al.
CELL DEATH AND DIFFERENTIATION (2021)
OTUB1 stabilizes mismatch repair protein MSH2 by blocking ubiquitinationy
Qiong Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc
Jianchao Ge et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
The functions and regulation of Otubains in protein homeostasis and diseases
Qiong Zhu et al.
AGEING RESEARCH REVIEWS (2021)
MYC protein interactors in gene transcription and cancer
Corey Lourenco et al.
NATURE REVIEWS CANCER (2021)
Target gene-independent functions of MYC oncoproteins
Apoorva Baluapuri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat
Yang Dong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer
Matthew Saldana et al.
ENDOCRINE-RELATED CANCER (2019)
The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11
Tong Liu et al.
CANCER RESEARCH (2019)
Preventing abnormal NF-κB activation and autoimmunity by Otub1-mediated p100 stabilization
Yanchuan Li et al.
CELL RESEARCH (2019)
Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer
Tingting Yang et al.
CANCER RESEARCH (2019)
Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth
Qingding Wang et al.
CANCER RESEARCH (2018)
PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer
Tingting Yang et al.
ONCOGENE (2018)
OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability
Honghong Zhou et al.
ONCOGENE (2018)
Classical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2
Priya Londhe et al.
FRONTIERS IN ONCOLOGY (2018)
Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells
Dongyeon Kim et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Silencing of OTUB1 inhibits migration of human glioma cells in vitro
Li Xu et al.
NEUROPATHOLOGY (2017)
STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells
Man Li et al.
ONCOTARGET (2017)
MYC and tumor metabolism: chicken and egg
Francesca R. Dejure et al.
EMBO JOURNAL (2017)
Expression of OTUB1 in hepatocellular carcinoma and its effects on HCC cell migration and invasion
Qinggan Ni et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2017)
Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo
Peng Wang et al.
ACTA NEUROPATHOLOGICA (2017)
OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance
U. Karunarathna et al.
ONCOGENE (2016)
OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitination
Maria Francesca Baietti et al.
EMBO MOLECULAR MEDICINE (2016)
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
Dai Horiuchi et al.
NATURE MEDICINE (2016)
Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation
Xinde Zheng et al.
eLife (2016)
OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo
Diego Iglesias-Gato et al.
MOLECULAR CANCER (2015)
The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc
Xiao-Xin Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
MYC and metabolism on the path to cancer
Annie L. Hsieh et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer
J. Pan et al.
ONCOGENE (2015)
OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer
Yi Zhou et al.
MOLECULAR CANCER (2014)
Wnt6 Is Expressed in Granulomatous Lesions of Mycobacterium tuberculosis-Infected Mice and Is Involved in Macrophage Differentiation and Proliferation
Kolja Schaale et al.
JOURNAL OF IMMUNOLOGY (2013)
Deubiquitylation and stabilization of PTEN by USP13
Jinsong Zhang et al.
NATURE CELL BIOLOGY (2013)
OTUB1 enhances TGFβ signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3
Lina Herhaus et al.
NATURE COMMUNICATIONS (2013)
Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1
Xiao-Xin Sun et al.
EMBO JOURNAL (2012)
Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells
Jong-Seok Moon et al.
BIOCHEMICAL JOURNAL (2011)
Regulation of Virus-triggered Signaling by OTUB1-and OTUB2-mediated Deubiquitination of TRAF3 and TRAF6
Shu Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Hypoxia-inducible factor I and dysregulated c-myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1
Jung-Whan Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The ubiquitin-specific protease USP28 is required for MYC stability
Nikita Popov et al.
NATURE CELL BIOLOGY (2007)
Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function
Stephen R. Hann
SEMINARS IN CANCER BIOLOGY (2006)
The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis
Dalia Barsyte-Lovejoy et al.
CANCER RESEARCH (2006)
Ubiquitylation and cell signaling
K Haglund et al.
EMBO JOURNAL (2005)
分享论文
